Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2015-04-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Intranasal and Oral Administration of Oxytocin on Responses to Emotional Scenes
NCT05532501
Effects of Intranasal Oxytocin on Emotion Regulation
NCT03055546
Oxytocin Effects on Self and Other Processing
NCT02963194
Effects of Oxytocin on Reinforcement Learning
NCT03846271
Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
NCT03060031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
male oxytocin group
male subjects with oxytocin treatment
oxytocin treatment
intranasal administration of oxytocin (40 IU)
female oxytocin group
female subjects with oxytocin treatment
oxytocin treatment
intranasal administration of oxytocin (40 IU)
male placebo group
male subjects with placebo treatment
placebo treatment
intranasal administration of placebo (40 IU)
female placebo group
female subjects with placebo treatment
placebo treatment
intranasal administration of placebo (40 IU)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin treatment
intranasal administration of oxytocin (40 IU)
placebo treatment
intranasal administration of placebo (40 IU)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnant,menstruating,taking oral contraceptives
* medical or psychiatric illness.
19 Years
28 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Kendrick, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China, Sichuan
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.